Aerpio Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 4.771 million compared to operating Income of USD 9.256 million a year ago. Net loss was USD 4.408 million compared to net income of USD 9.276 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to basic earnings per share from continuing operations of USD 0.23 a year ago. For the half year, operating loss was USD 10.374 million compared to operating Income of USD 5.141 million a year ago. Net loss was USD 8.849 million compared to net income of USD 5.357 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to basic earnings per share from continuing operations of USD 0.13 a year ago.